
Net earnings attributable to Procter & Gamble increased 15% to $4.5 billion while EPS rose 17% to $1.83. Core EPS also grew 17% to $1.83.
Revenue and earnings both beat expectations.
For FY2024, all-in sales growth is expected to be 2-4% while organic sales growth is expected to be 4-5%.
The stock gained over 1% in premarket hours on Wednesday.
Prior performance
